Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Share News (VER)

  • There is currently no data for VER

TechMARK movers: Pharma disappointments hit index

Tue, 30th Mar 2010 15:52
TechMARK is dominated by pharma companies who have disappointed the market in the past week. Antisoma and Vernalis continue their declines. Shares in cancer drug developer Antisoma plunged following news that Novartis has halted a Phase III trial for lung cancer treatment ASA404. Vernalis was hit by disappointing results from the IN-STEP Phase IIb study for the safety and efficacy of V3381 (indantadol) as a treatment for neuropathic pain due to diabetes.Shares in human tissue research services provider Asterand fell even though its 2009 results were in line with the expectations of joint broker Daniel Stewart. Revenues fell from £15.2m to £12m but stripping out non-recurring revenues they rose by one-fifth. Asterand swung from a profit of £3.9m to a loss of £1.1m. Excluding one-offs, Asterand was close to breakeven. Daniel Stewart forecasts a profit of £700,000 for 2010.The Vectura share price has stabilised and edged up slightly following its sharp falls last week. The pharma company declined due to its agreement to take full control of the US development of asthma treatment VR315 back from Sandoz. Yesterday, FinnCap published a note on Vectura which argued that this is a significant positive move for Vectura. Finncap argues that: "The regulatory and commercial risks associated with VR315 in the US are unchanged in our view. Vectura now receives 100% of the revenue from the product rather than one third of the net profit. We believe the risk/reward ratio has improved significantly".FinnCap has a price target of 120p a share. Vidacos Nominees has cut its stake in Vectura slightly to 6.82%.FTSE TechMARK - RisersCryptologic Ld (CRP) 245.00p +6.52%Morse (MOR) 39.00p +4.00%Phoenix IT Group (PNX) 270.00p +3.85%Domino Printing (DNO) 392.50p +3.29%Intec Telecom Systems (ITL) 96.25p +2.67%Vectura Group (VEC) 46.00p +2.22%Psion (PON) 83.75p +1.82%Xaar (XAR) 101.50p +1.50%Kofax (KFX) 218.00p +1.40%Wolfson Microelectronics (WLF) 150.25p +1.18%FTSE TechMARK - FallersAsterand (ATD) 15.00p -16.67%Antisoma (ASM) 6.84p -14.50%Vernalis (VER) 56.50p -8.13%Emblaze (BLZ) 42.00p -6.67%Torotrak (TRK) 24.00p -4.00%BATM Advanced (BVC) 37.25p -3.87%Skyepharma (SKP) 46.00p -3.66%NCC Group (NCC) 375.00p -3.60%Sinclair Pharma (SPH) 29.50p -3.28%ProStrakan (PSK) 86.25p -3.09%

Related News

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances
1 Oct 2021

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2
29 Sep 2021

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

(Adds background)LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British supermarket Morrisons will be decided at an auction on Saturday, when ...

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover
20 Sep 2021

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

Vernalis PLC News

Seneca Global Adds Aberdeen New Thai Director Gilding To Board
6 Mar 2020

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)
10 Oct 2018

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)

LONDON (Alliance News) - Shares in Vernalis PLC were temporarily suspended from trading on AIM on Wednesday as requested by the company pending an ann...

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders
2 Oct 2018

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders

LONDON (Alliance News) - Vernalis PLC on Tuesday said its acquisition by Ligand Holdings UK has been approved by shareholders.The pharmaceutical compa...

UK Shareholder Meetings Calendar - Next 7 Days
25 Sep 2018

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 26 SeptemberIMIMobileHornbyNCC GroupPZ CussonsGateley 27

Vernalis Non-Exec Director Gilham Leaves Ahead Of Takeover
16 Aug 2018

Vernalis Non-Exec Director Gilham Leaves Ahead Of Takeover

LONDON (Alliance News) - Pharmaceutical firm Vernalis PLC on Thursday said Ian Gilham is leaving his role as a non-executive director.Chairman Peter F...

Ligand Pharma to buy Vernalis for just under £33m in cash
9 Aug 2018

Ligand Pharma to buy Vernalis for just under £33m in cash

(Sharecast News) - AIM-listed Vernalis has agreed to be bought by Ligand UK, a subsidiary of California-based Ligand Pharmaceuticals, for 6.2p per sha...

Ligand Holdings UK Agrees To Buy Vernalis For GBP32.7 Million
9 Aug 2018

Ligand Holdings UK Agrees To Buy Vernalis For GBP32.7 Million

LONDON (Alliance News) - Pharmaceutical company Vernalis PLC said Thursday that it reached an agreement to be taken over by Ligand Holdings UK Ltd.Lig...

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts
14 Jun 2018

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2....